# Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study

**Authors:** Siyang Cao, Yihao Wei, Yaohang Yue, Yingqi Chen, Shuai Liao, Aikang Li, Peng Liu, Ao Xiong, Hui Zeng

PMC · DOI: 10.3389/fphar.2024.1366852 · Frontiers in Pharmacology · 2024-02-14

## TL;DR

This study maps the growth of research on how traditional Chinese medicine affects ferroptosis, a type of cell death, over the past 11 years.

## Contribution

The study provides a comprehensive scientometric analysis of TCM and ferroptosis research, identifying key contributors and emerging trends.

## Key findings

- China dominates research output with 71.99% of publications.
- Institutions like Guangzhou University of Chinese Medicine are major contributors.
- Hepatocellular carcinoma and liver-related diseases are key focus areas.

## Abstract

In the past 11 years, there has been a surge in studies exploring the regulatory effect of Traditional Chinese Medicine (TCM) on ferroptosis. However, a significant gap persists in comprehensive scientometric analysis and scientific mapping research, especially in tracking the evolution, primary contributors, and emerging research focal points. This study aims to comprehensively update the advancements in targeting ferroptosis with various TCMs during the previous 11 years. The data, covering the period from 1 January 2012, to 30 November 2023, were retrieved from the Web of Science database. For in-depth scientometric and visualized analyses, a series of advanced analytical instruments were employed. The findings highlight China’s predominant role, accounting for 71.99% of total publications and significantly shaping research in this domain. Noteworthy productivity was observed at various institutions, including Guangzhou University of Chinese Medicine, Chengdu University of Traditional Chinese Medicine, and Zhejiang University. Thomas Efferth emerged as the foremost author within this field, while Frontiers in Pharmacology boasted the highest publication count. This study pinpointed hepatocellular carcinoma, chemical and drug-induced liver injury, mitochondrial diseases, acute kidney injury, and liver failure as the most critical disorders addressed in this research realm. The research offers a comprehensive bibliometric evaluation, enhancing our understanding of the present status of TCM therapy in managing ferroptosis-related diseases. Consequently, it aids both seasoned researchers and newcomers by accelerating access to vital information and fostering innovative concept extraction within this specialized field.

## Linked entities

- **Diseases:** hepatocellular carcinoma (MONDO:0007256), acute kidney injury (MONDO:0002492), liver failure (MONDO:0100192)

## Full-text entities

- **Diseases:** liver failure (MESH:D017093), mitochondrial diseases (MESH:D028361), hepatocellular carcinoma (MESH:D006528), acute kidney injury (MESH:D058186)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10921231/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10921231/full.md

## References

131 references — full list in the complete paper: https://tomesphere.com/paper/PMC10921231/full.md

---
Source: https://tomesphere.com/paper/PMC10921231